Kyntra Bio, Inc. (KYNB) is a biopharmaceutical company engaged in preclinical development and clinical trials of product candidates. The company previously operated a roxadustat business in China, which was being divested. Kyntra Bio focuses on developing therapeutics, pursuing regulatory approvals, and building commercial functions, with operations funded through cash, cash equivalents, and accounts receivable.
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108346 | EDGAR | 80K words |
| 2025-03-17 | 2024-12-31 | 0000950170-25-040280 | EDGAR | 100K words |
| 2024-02-26 | 2023-12-31 | 0000950170-24-020161 | EDGAR | 111K words |
| 2023-02-27 | 2022-12-31 | 0000950170-23-004668 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007632 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009871 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001564590-20-008161 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001564590-19-004979 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003508 | EDGAR | — |
| 2017-03-01 | 2016-12-31 | 0001564590-17-003095 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001193125-26-349183 | EDGAR | 50K words |
| 2025-11-10 | 2025-09-30 | 0001193125-25-274241 | EDGAR | 53K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106549 | EDGAR | 59K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069203 | EDGAR | 56K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125388 | EDGAR | 64K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091808 | EDGAR | 62K words |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053554 | EDGAR | 58K words |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059394 | EDGAR | 67K words |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039070 | EDGAR | 66K words |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018814 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022605 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0000950170-22-015530 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-31 | 0001193125-26-377059 | EDGAR | 1K words |
| 2026-08-13 | 0001193125-26-349141 | EDGAR | 3K words |
| 2026-03-16 | 0001193125-26-108324 | EDGAR | 3K words |
| 2026-01-07 | 0001193125-26-006327 | EDGAR | 1K words |
| 2025-11-10 | 0001193125-25-274192 | EDGAR | 3K words |
| 2025-11-06 | 0001193125-25-269529 | EDGAR | 1K words |
| 2025-09-05 | 0000921299-25-000007 | EDGAR | 3K words |
| 2025-09-02 | 0000950170-25-112341 | EDGAR | 1K words |
| 2025-08-18 | 0000950170-25-109571 | EDGAR | 0K words |
| 2025-08-14 | 0000950170-25-108280 | EDGAR | 2K words |
221 total filings indexed. 189 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000921299 |
| Ticker | KYNB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.kyntrabio.com |
| Listed | 2014-11-14 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/KYNB (~200 tokens, structured JSON with cryptographic provenance)